IN2012DN01878A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01878A IN2012DN01878A IN1878DEN2012A IN2012DN01878A IN 2012DN01878 A IN2012DN01878 A IN 2012DN01878A IN 1878DEN2012 A IN1878DEN2012 A IN 1878DEN2012A IN 2012DN01878 A IN2012DN01878 A IN 2012DN01878A
- Authority
- IN
- India
- Prior art keywords
- cancer
- diseases
- administration
- prevention
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27575409P | 2009-09-02 | 2009-09-02 | |
| PCT/US2010/047615 WO2011028860A2 (en) | 2009-09-02 | 2010-09-02 | Compounds and compositions for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01878A true IN2012DN01878A (enrdf_load_stackoverflow) | 2015-08-21 |
Family
ID=43625764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1878DEN2012 IN2012DN01878A (enrdf_load_stackoverflow) | 2009-09-02 | 2010-09-02 |
Country Status (9)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101629642B1 (ko) | 2014-06-25 | 2016-06-13 | 서울대학교산학협력단 | 피퍼롱구민을 유효성분으로 함유하는 지방간 예방용 식품 조성물, 지방간 치료용 약학 조성물, 지방간 치료용 동물 의약품 및 사료 조성물 |
| GB201715008D0 (en) * | 2017-09-18 | 2017-11-01 | Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa | TRPV2 Antagonists |
| KR102811108B1 (ko) | 2018-12-27 | 2025-05-23 | 주식회사 티에스디라이프사이언스 | 피퍼롱구민을 함유하는 담도폐쇄증 치료 또는 예방용 의약 조성물 |
| CN110002987B (zh) * | 2019-03-22 | 2020-09-15 | 南通大学 | 苯基亚烯丙基环己烯酮衍生物及制备方法和用途 |
| CN117229205B (zh) * | 2023-09-14 | 2025-03-21 | 中国医学科学院基础医学研究所 | 苯基丙烯酰胺类rhbdd1抑制剂制备方法及制药用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2677892A1 (en) * | 2007-02-14 | 2008-12-04 | Mars, Incorporated | Neurogenic compounds |
| WO2008112195A1 (en) * | 2007-03-09 | 2008-09-18 | Bioseek, Inc. | Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| CN102146054A (zh) | 2010-02-10 | 2011-08-10 | 新昌县来益科技开发有限公司 | 荜茇酰胺衍生物及其药物组合物和在制备抑制肿瘤生长的药物中的用途 |
-
2010
- 2010-09-02 BR BR112012004701A patent/BR112012004701A2/pt not_active IP Right Cessation
- 2010-09-02 JP JP2012528029A patent/JP2013503888A/ja active Pending
- 2010-09-02 KR KR1020127007113A patent/KR20120104165A/ko not_active Withdrawn
- 2010-09-02 CN CN2010800418987A patent/CN102625805A/zh active Pending
- 2010-09-02 WO PCT/US2010/047615 patent/WO2011028860A2/en active Application Filing
- 2010-09-02 CA CA2772614A patent/CA2772614A1/en not_active Abandoned
- 2010-09-02 AU AU2010289493A patent/AU2010289493A1/en not_active Abandoned
- 2010-09-02 IN IN1878DEN2012 patent/IN2012DN01878A/en unknown
- 2010-09-02 EP EP10814469A patent/EP2473506A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2473506A2 (en) | 2012-07-11 |
| CN102625805A (zh) | 2012-08-01 |
| BR112012004701A2 (pt) | 2018-06-12 |
| JP2013503888A (ja) | 2013-02-04 |
| EP2473506A4 (en) | 2013-03-06 |
| CA2772614A1 (en) | 2011-03-10 |
| AU2010289493A1 (en) | 2012-04-19 |
| WO2011028860A2 (en) | 2011-03-10 |
| WO2011028860A3 (en) | 2011-07-21 |
| KR20120104165A (ko) | 2012-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
| MY157124A (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| WO2012024530A3 (en) | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods | |
| WO2011082273A3 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
| WO2011082267A8 (en) | Substituted triazolo-pyrazine compounds | |
| MX2011006959A (es) | Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina. | |
| WO2010132697A3 (en) | Methods and compositions for treatment | |
| WO2011082266A3 (en) | Substituted heterocyclic compounds | |
| UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
| MY162903A (en) | Methods of treatment of pancreatic cancer | |
| MX370721B (es) | Compuestos y composiciones novedosas para atacar las células madre del cáncer. | |
| MX339862B (es) | Compuestos imidazopiridinil-aminopiridina substituidos. | |
| IL207310A0 (en) | Vaccine compositions | |
| WO2010059004A3 (ko) | 스네일-p53 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제 | |
| WO2011123678A3 (en) | Substituted benzo-pyrido-triazolo-diazepine compounds | |
| WO2011129936A3 (en) | Compositions and methods for the prevention and treatment of cancer | |
| WO2011082268A3 (en) | Substituted naphthalenyl-pyrimidine compounds | |
| IN2012DN01878A (enrdf_load_stackoverflow) | ||
| MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
| WO2011044523A3 (en) | Compositions and methods for treating obesity | |
| WO2011100330A3 (en) | Compositions and methods for preventing or treating a human parvovirus infection | |
| NZ595440A (en) | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds | |
| PH12012500824A1 (en) | Oral composition for treating oral malodor | |
| WO2012061342A3 (en) | Substituted benzo-imidazo-pyrido-diazepine compounds | |
| WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth |